========================================================
GBM FALSE ATTRACTOR ANALYSIS
OrganismCore — False Attractor Framework
Cancer Validation #3
February 28, 2026
========================================================
File found.
========================================================
STEP 1: LOADING EXPRESSION MATRIX
========================================================
File: GSM3828672_Smartseq2_GBM_IDHwt_processed_TPM.tsv.gz
Loading TPM matrix (genes x cells)...
This will take ~60 seconds...
Full matrix: (23686, 7930) (genes x cells)

Target genes found:   ['OLIG2', 'SOX10', 'MBP', 'MOG', 'PLP1', 'PDGFRA', 'SOX2', 'EGFR', 'NES', 'CDX2', 'SPI1', 'KLF4', 'IRF8', 'OLIG1', 'GFAP', 'MKI67']

Extracted: (7930, 16) (cells x genes)
Log1p transformed.
Cached: ./gbm_saddle_results/expr_cache.csv
========================================================
STEP 2: CELL STATE CLASSIFICATION
========================================================
Strategy: marker-based scoring
  Normal oligodendrocyte = high MBP/MOG/PLP1/SOX10
  OPC-like false attractor = high PDGFRA/SOX2/EGFR/NES

Myelination markers available: ['MBP', 'MOG', 'PLP1', 'SOX10']
Progenitor markers available:  ['PDGFRA', 'SOX2', 'EGFR', 'NES']

Oligo score:      mean=0.377  max=2.282
Progenitor score: mean=0.797  max=1.874

Thresholds (top 20%):
  Oligo:      0.585
  Progenitor: 1.224

Cell state distribution:
cell_state
Ambiguous       5262
Normal_Oligo    1334
OPC_like        1334
Name: count, dtype: int64

Normal oligodendrocytes: 1334
OPC-like (false attractor): 1334

Marker expression by cell state:
GENE            MBP    MOG   PLP1  SOX10  PDGFRA   SOX2   EGFR    NES
cell_state                                                           
Ambiguous     0.159  0.421  0.237  0.149   0.551  0.717  0.898  0.546
Normal_Oligo  0.915  0.896  1.663  0.822   0.755  0.818  0.516  0.507
OPC_like      0.095  0.387  0.276  0.094   1.383  1.274  1.816  1.177
========================================================
STEP 3: SADDLE POINT SIGNATURE
========================================================
FRAMEWORK PREDICTION (GBM):
  Reference:  Normal_Oligo
              (myelinating oligodendrocytes)
  Blocked:    OPC_like
              (false attractor)

  SUPPRESSED candidates:
    ['OLIG2', 'SOX10', 'MBP', 'MOG', 'PLP1']
  ELEVATED predicted:
    ['PDGFRA', 'SOX2', 'EGFR', 'NES']
  CONTROLS (prior cancer switch genes):
    ['CDX2', 'SPI1', 'KLF4', 'IRF8']

n normal oligo:  1334
n OPC-like:      1334

OLIG2    [CANDIDATE ] | normal=0.663 blocked=0.806 | elevated   +21.5%          | p=1.0000     | ✗ INVERTED
SOX10    [CANDIDATE ] | normal=0.822 blocked=0.094 | suppressed +88.6%          | p=5.50e-188 *** | ✓ CONFIRMED
MBP      [CANDIDATE ] | normal=0.915 blocked=0.095 | suppressed +89.6%          | p=1.97e-143 *** | ✓ CONFIRMED
MOG      [CANDIDATE ] | normal=0.896 blocked=0.387 | suppressed +56.9%          | p=2.97e-91 *** | ✓ CONFIRMED
PLP1     [CANDIDATE ] | normal=1.663 blocked=0.276 | suppressed +83.4%          | p=1.27e-280 *** | ✓ CONFIRMED
PDGFRA   [ELEVATED  ] | normal=0.755 blocked=1.383 | elevated   +83.1%          | p=1.0000     | ✓ ELEVATED
SOX2     [ELEVATED  ] | normal=0.818 blocked=1.274 | elevated   +55.7%          | p=1.0000     | ✓ ELEVATED
EGFR     [ELEVATED  ] | normal=0.516 blocked=1.816 | elevated   +252.2%         | p=1.0000     | ✓ ELEVATED
NES      [ELEVATED  ] | normal=0.507 blocked=1.177 | elevated   +132.3%         | p=1.0000     | ✓ ELEVATED
CDX2     [CONTROL   ] | normal=0.000 blocked=0.001 | elevated   +97487.4%       | p=0.9215     | ✗ CONTROL UNEXPECTED
SPI1     [CONTROL   ] | normal=0.017 blocked=0.003 | suppressed +81.0%          | p=0.0021 **  | ✗ CONTROL UNEXPECTED
KLF4     [CONTROL   ] | normal=0.270 blocked=0.185 | suppressed +31.4%          | p=5.53e-05 *** | ✗ CONTROL UNEXPECTED
IRF8     [CONTROL   ] | normal=0.051 blocked=0.006 | suppressed +87.6%          | p=4.94e-08 *** | ✗ CONTROL UNEXPECTED
OLIG1    [SCAFFOLD  ] | normal=1.123 blocked=1.367 | elevated   +21.7%          | p=1.0000     | ~ SCAFFOLD
GFAP     [SCAFFOLD  ] | normal=0.799 blocked=1.017 | elevated   +27.2%          | p=1.0000     | ~ SCAFFOLD

========================================================
GBM FRAMEWORK PREDICTION RESULT
========================================================
Switch genes confirmed:  4/5
Switch genes partial:    0/5
Elevated as predicted:   4/4
Controls as expected:    0/4

** PARTIAL CONFIRMATION **
Consistent with framework.
========================================================
STEP 4: GENERATING FIGURE
========================================================
Figure saved: ./gbm_saddle_results/gbm_saddle_figure.png
========================================================
STEP 5: CROSS-CANCER SUMMARY
========================================================

CROSS-CANCER FALSE ATTRACTOR ANALYSIS
OrganismCore — February 28, 2026
============================================================

THE PRINCIPLE:
  Cancer is a false attractor in the Waddington
  epigenetic landscape. Malignant cells are stuck
  below the differentiation threshold — a ceiling
  imposed by suppression of lineage-specific switch
  genes. The switch genes are identifiable by their
  expression profile: suppressed in the blocked
  population relative to the normal differentiated
  endpoint.

CANCER 1: AML — Acute Myeloid Leukemia
  Lineage:    Myeloid
  Block:      GMP-like vs CD14+ monocytes
  Switch genes (myeloid differentiation):
    SPI1:  90.5% suppressed  p=0.00e+00 ***
    KLF4:  94.7% suppressed  p=0.00e+00 ***
    IRF8:  69.5% suppressed  p=0.00e+00 ***

CANCER 2: CRC — Colorectal Cancer
  Lineage:    Epithelial/Colonocyte
  Block:      Epithelial 2 (cycling) vs Epithelial 1
  Switch genes (colonocyte differentiation):
    CDX2:  79.5% suppressed  p=3.89e-154 ***
  Unexpected: IRF8 elevated 211%
              (lineage infidelity)

CANCER 3: GBM — Glioblastoma
  Lineage:    Neural/Oligodendrocyte
  Block:      OPC-like vs normal oligodendrocytes
  Switch genes (myelination/oligodendrocyte):
    OLIG2   : -21.5% suppressed  p=1.00e+00   [INVERTED]
    SOX10   :  88.6% suppressed  p=5.50e-188 ***  [CONFIRMED]
    MBP     :  89.6% suppressed  p=1.97e-143 ***  [CONFIRMED]
    MOG     :  56.9% suppressed  p=2.97e-91 ***  [CONFIRMED]
    PLP1    :  83.4% suppressed  p=1.27e-280 ***  [CONFIRMED]

  Elevated (false attractor drivers):
    PDGFRA  :  83.1% elevated  [ELEVATED AS PREDICTED]
    SOX2    :  55.7% elevated  [ELEVATED AS PREDICTED]
    EGFR    : 252.2% elevated  [ELEVATED AS PREDICTED]
    NES     : 132.3% elevated  [ELEVATED AS PREDICTED]

  Controls (prior cancer switch genes):
    CDX2    : suppression=-97487.4%  [CONTROL UNEXPECTED]
    SPI1    : suppression=+81.0%  [CONTROL UNEXPECTED]
    KLF4    : suppression=+31.4%  [CONTROL UNEXPECTED]
    IRF8    : suppression=+87.6%  [CONTROL UNEXPECTED]

ZERO GENE OVERLAP (confirmed):
  AML:  SPI1, KLF4, IRF8   — myeloid TFs
  CRC:  CDX2               — colonocyte TF
  GBM:  OLIG2, SOX10, MBP, MOG, PLP1
        — oligodendrocyte/myelin TFs and proteins

  None of these gene sets overlap.
  The framework finds lineage-specific gates
  in each cancer type.
  The lock is the same. The gates are different.

THERAPEUTIC IMPLICATIONS:
  AML:  CRISPRa SPI1 + KLF4 + IRF8
  CRC:  CRISPRa CDX2  +  CRISPRi IRF8
  GBM:  CRISPRa [confirmed switch genes above]

  Same intervention logic. Different targets.
  Computable from public data.
  Testable with standard tools.

============================================================
Eric Robert Lawson — OrganismCore
February 28, 2026

Saved: ./gbm_saddle_results/cross_cancer_summary.txt

========================================================
COMPLETE
Results: ./gbm_saddle_results/
Files:
  ./gbm_saddle_results/gbm_saddle_figure.png
  ./gbm_saddle_results/gbm_saddle_results.csv
  ./gbm_saddle_results/cross_cancer_summary.txt
========================================================
